May 24, 2020

With dozens of COVID-19 vaccine candidates in development around the world, a massive challenge looms on the horizon: deciding who gets access to a successful vaccine first, and whether countries can produce enough for everyone. Wendy Mesley speaks to two people leading two of the most promising made-in-Canada vaccines about how to make sure everyone gets access. A handful of companies now have permanent work from home policies after being forced to move employees off-site to maintain physical distancing amid the COVID-19 pandemic. But this policy may come at a cost, as the demand for software that can monitor employees' productivity increases. Should bosses be allowed to spy? With dozens of COVID-19 vaccine candidates in development around the world, a massive challenge looms on the horizon: deciding who gets access to a successful vaccine first, and whether countries can produce enough for everyone. Most countries, including Canada, are banking on global co-operation. But there are already signs that political interference may complicate where the early candidates will be produced, and where the first orders will be sent. In the past, Canada has relied heavily on other countries to help manufacture its vaccines.